Paraoxonase gene polymorphism, serum lipid, and oxidized low-density lipoprotein in preeclampsia

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 133, Issue 1, 2007, Pages 47-52

  Kim, Young Ju ^a   Park, Hyesook ^a   Lee, Hwa Young ^a   Ahn, Young mo ^a   Ha, Eun Hee ^a   Suh, Suk Hyo ^a   Pang, Myung Geol ^b  

^a Ewha Womans University   (South Korea)

^b Chung Ang University   (South Korea)

Author keywords

Gene; Oxidized low density lipoprotein; Paraoxonase; Preeclampsia

Indexed keywords

ARYLDIALKYLPHOSPHATASE 1; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OXIDIZED LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; ATHEROGENIC DIET; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; ENDOTHELIAL DYSFUNCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE AMPLIFICATION; GENE FREQUENCY; GENOTYPE; HUMAN; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; POLYMERASE CHAIN REACTION; PREECLAMPSIA; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; STATISTICAL SIGNIFICANCE; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 34250697416     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2006.07.046     Document Type: Article

References (30)

1. Gratacos E. Lipid-mediated endothelial dysfunction: a common factor to preeclampsia and chronic vascular disease. Eur J Obstet Gynecol Reprod Biol 92 (2000) 63-66
2. Hubel C.A. Oxidative stress in the pathogenesis of preeclampsia. Proc Soc Exp Biol Med 222 (1999) 222-235
3. Pasqualini L., Cortese C., Marchesi S., et al. Paraoxonase-1 activity modulates endothelial function in patients with peripheral arterial disease. Atherosclerosis 183 (2005) 349-354
4. Mackness M.I., Arrol S., and Durrington P.N. Paraoxonase prevents accumulation of lipoperoxides in low-density lipoprotein. FEBS Lett 286 (1991) 152-154
5. Costa L.G., Cole T.B., Jarvik G.P., and Furlong C.E. Functional genomics of the paraoxonase (PON1) polymorphisms: effects on pesticide sensitivity, cardiovascular disease, and drug metabolism. Annu Rev Med 54 (2003) 371-392
6. Mackness B., Macness M.I., Arrol S., Turkie W., and Durrington P.N. Effect of the human serum paraoxonase 55 and 192 genetic polymorphisms on the protection by high density lipoprotein against low density lipoprotein oxidative modification. FEBS Lett 423 (1998) 57-60
7. Mackness B., Durrington P.N., and Mackness M.I. Human serum paraoxonase. Gen Pharmacol 31 (1998) 329-336
8. Chen D., Hu Y., Chen C., et al. Polymorphisms of the paraoxonase gene and risk of preterm delivery. Epidemiology 15 (2004) 466-470
9. Sattar N., Bendomir A., Berry C., Shepherd J., Greer I.A., and Packard C.J. Lipoprotein subfraction concentrations in preeclampsia: pathogenic parallels to atherosclerosis. Obstet Gynecol 89 (1997) 403-408
10. Ware-Jauregui S., Sanchez S.E., Zhang C., Laraburre G., King I.B., and Williams M.A. Plasma lipid concentrations in preeclamptic and normotensive Peruvian women. Int J Gynecol Obstet 67 (1999) 147-155
11. Chapman M.J., and Bruckert E. The atherogenic role of triglycerides and small, dense low density lipoproteins: impact of ciprofibrate therapy. Atherosclerosis 124 suppl (1996) S21-S28
12. Li D., and Mehta J.L. 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors protect against oxidized low-density lipoprotein induced endothelial dysfunction. Endothelium 10 (2003) 17-21
13. Uzun H., Benian A., Madazli R., Topcuoglu M.A., Aydin S., and Albayrak M. Circulating oxidized low-density lipoprotein and paraoxonase activity in preeclampsia. Gynecol Obstet Invest 60 (2005) 195-200
14. Branch D.W., Mitchell M.D., Miller E., Palinski W., and Witztum J.L. Preeclampsia and serum antibodies to oxidized low density lipoprotein. Lancet 343 (1994) 645-646
15. Redman C.W. Current topic: preeclampsia and the placenta. Placenta 12 (1991) 301-308
16. National High Blood Pressure Education Program: Working Group Report on High Blood Pressure in pregnancy. Am J Obstet Gynecol 2000;183:51.
17. Cascorbi I., Laule M., Mrozikiewicz P.M., et al. Mutations in the human paraoxonase 1 gene: frequencies, allelic linkage, and association with coronary artery disease. Pharmacogenetics 9 (1999) 755-761
18. Kumru S., Aydin S., Gursu M.F., and Ozcan Z. Changes of serum paraoxonase (an HDL-cholesterol-associated lipophilic antioxidant) and arylesterase activities in preeclamptic women. Eur J Obstet Gynecol Reprod Biol 114 (2004) 177-181
19. Sarandol E., Safak O., Dirican M., and Uncu G. Oxidizability of apolipoprotein B-containing lipoproteins and serum paraoxonase/arylesterase activities in preeclampsia. Clin Biochem 37 (2004) 990-996
20. Gamboa R., Zamora J., Rodriguez-Perez J.M., et al. Distribution of paraoxonase PON1 gene polymorphisms in Mexican populations. Its role in lipid profile. Exp Mol Pathol 80 (2006) 85-90
21. Park HS, Min JW, Park BH, et al. Paraoxonase polymorphism and vitamin levels during pregnancy affect maternal oxidative stress and their neonatal birth weights. Reprod Toxicol 2006 March 3; [Epub ahead of print].
22. Winkler K., Wetzka B., Hoffmann M.M., et al. Triglyceride-rich lipoproteins are associated with hypertension in preeclampsia. J Clin Endocrinol Metab 88 (2003) 1162-1166
23. Belo L., Caslake M., Gaffney D., et al. Changes in LDL size and HDL concentrations in normal and preeclamptic pregnancies. Atherosclerosis 162 (2002) 425-432
24. Martin U., Davies C., Hayavi S., Hartland A., and Dunne F. Is normal pregnancy atherogenic?. Clin Sci 96 (1999) 421-425
25. Zhu X.D., Bonet B., and Knopp R.H. 17β-Estradiol, progesterone, and testosterone inversely modulate low-density lipoprotein oxidation and cytotoxicity in cultured placental trophoblast and macrophages. Am J Obstet Gynecol 177 (1997) 196-209
26. Serin I.S., Kula M., Basbug M., Unluhizarci K., Gucer S., and Tayyar M. Androgen levels of preeclamptic patients in the third trimester of pregnancy and six weeks after delivery. Acta Obstet Gynecol Scand 80 (2001) 1009-1013
27. 2 ) by vascular tissues. Prostaglandins 37 (1989) 401-409
28. Sanchez S.E., Williams M.A., Muy-Rivera M., Qiu C., Vadachkoria S., and Bazul V. A case-control study of oxidized low density lipoproteins and preeclampsia risk. Gynecol Endocrinol 21 4 (2005) 193-199
29. Raijmakers M.T., van Tits B.J., Hak-Lemmers H.L., and Roes E.M. Low plasma levels of oxidized low density lipoprotein in preeclampsia. Acta Obstet Gynecol Scand 83 (2004) 1173-1177
30. Lee H., Park H., Kim Y.J., et al. Expression of lectin-like oxidized low density lipoprotein receptor-1 (LOX-1) in human preeclamptic placenta: possible implications in the process of trophoblast apoptosis. Placenta 26 (2005) 226-233